LIONNS-D2 Project - Production of T3S API, IMP and FDF

A Contract Award Notice
by CARDIFF UNIVERSITY

Source
Find a Tender
Type
Contract ()
Duration
not specified
Value
€954K
Sector
MISCELLANEOUS
Published
24 Oct 2025
Delivery
not specified
Deadline
n/a

Related Terms

Location

Geochart for 1 buyers and 1 suppliers

1 buyer

1 supplier

Description

Cardiff University's School of Medicine is procuring the manufacture of a novel investigational medicinal product (IMP), Triiodothyronine sulphate (T3S), for use in a Phase 2b clinical trial. The service includes the production of the active pharmaceutical ingredient (API), the IMP, and the finished drug formulation (FDF) in blister packs. This bespoke drug is intended for hypothyroid patients with a specific genetic variation affecting thyroid hormone metabolism. The supplier will manufacture the product to GMP standards, using a validated Route of Synthesis supported by existing preclinical and toxicology data.

Award Detail

1 Ardena Holding NV (Mariakerke)
  • LIONNS-D2 Project - Production of T3S API, IMP and FDF
  • Reference: 1
  • Value: £953,600

CPV Codes

  • None found

Other Information

** PREVIEW NOTICE, please check Find a Tender for full details. **

Reference

  • ocds-h6vhtk-05d2df
  • FTS 068032-2025

Domains